Investment Banking
Private Placements, Mergers & Acquisitions, and Restructuring
Investment Management
Haoyue China Healthcare Fund
Track Record
Leveraging our deep sector expertise and comprehensive industry research, we provide investors with actionable insights and a holistic view of China's evolving Life Sciences and Healthcare landscape, covering key sectors including Biotech, Medtech,Healthcare Services, Digital Health, and Diagnostics & Precision Medicine.
Sectors
- Biopharma
- Medical Devices
- Healthcare Services & Digital Health
- IVD & Life Science
Round
- Series A funding
- Series B funding
- Series C funding
- Series D funding
- Series E funding
- Series F funding
- Pre-IPO
- Strategic Financing
- Crossover
- Others
Year
- 2026
- 2025
- 2024
- 2023
Our breadth and depth of industry reseach capabilities enable us to produce differentiated insights with a 360-degree view of China’s healthcare industry.
-
ShanghaiRm 2302, New Bund Center, 555 West Haiyang Rd, Pudong New Area, Shanghai -
Beijing3609, Taikang Financial Building, Building 1, Yard 38, North Rd of East 3rd Ring, Chaoyang District -
Shenzhen officeRm 1205,Shenzhen Metro Property Development Building, 6011-8 Shennan Avenue, Futian District.Shenzhen -
Hong Kong10th Floor, YF Life Tower, 33 Lockhart Road, Wan Chai, Hong Kong
